Survival Analysis in Metastasis Breast Cancer with HER-2 Type That Received Vinorelbine And Capecitabine Chemotherapy at Prof. Dr.I.G.N.G. Ngoerah Central General Hospital Andersen1*, Putu Anda Tusta Adiputra2, I B Made Suryawisesa2 Abstract Introduction: Breast cancer remains a leading cause of cancer-related mortality globally, particularly in developing regions. The HER-2 subtype